Business Context and Reporting Period
This Form 8-K was filed by Flora Growth Corp., not Zerostack Corp., on June 7, 2023, regarding corporate actions effective June 9, 2023. Flora Growth is incorporated in Ontario and its common shares trade on the Nasdaq Capital Market under the symbol FLGC.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial performance metrics.
Material Changes
- The Board approved a 1-for-20 reverse stock split of the Company’s common shares after shareholders authorized a ratio between 1-for-5 and 1-for-25.
- The reverse stock split becomes effective at 12:00:01 a.m. Eastern Time on June 9, 2023.
- Every 20 issued and outstanding common shares will be combined into one share.
- Trading is expected to begin on a split-adjusted basis at Nasdaq’s market open on June 9, 2023.
- The shares will receive new CUSIP number 339764201 but will continue trading on the Nasdaq Capital Market under FLGC.
- The split does not change shareholder ownership percentages, voting rights, authorized shares, or the stated terms of the common shares. Fractional shares will be rounded down to the nearest whole share.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance or operating outlook is provided. The principal unusual item is the reverse stock split, which changes the number of shares outstanding and the per-share trading price without, according to the filing, changing proportional ownership. The filing does not discuss liquidity risks, contingencies, or management forecasts.
Investor Verification Checklist
- Verify that the filing issuer is Flora Growth Corp., despite the request metadata identifying Zerostack Corp.
- Confirm the 1-for-20 reverse stock split effective time and the first split-adjusted trading date.
- Confirm the new CUSIP number and continued Nasdaq listing under FLGC.
- Review Exhibit 3.1 for the formal Articles Amendment and Exhibit 99.1 for the related press release.
- Assess the effect of the reverse split on shares outstanding, market price, outstanding securities, and any applicable equity compensation or convertible instruments.